A framework for stimulating economic investments to prevent emerging diseases.
Publication
, Journal Article
Schar, DL; Yamey, GM; Machalaba, CC; Karesh, WB
Published in: Bulletin of the World Health Organization
February 2018
Duke Scholars
Published In
Bulletin of the World Health Organization
DOI
EISSN
1564-0604
ISSN
0042-9686
Publication Date
February 2018
Volume
96
Issue
2
Start / End Page
138 / 140
Related Subject Headings
- United States
- Tropical Medicine
- Private Sector
- Pandemics
- Investments
- Humans
- Cost of Illness
- Communicable Diseases, Emerging
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schar, D. L., Yamey, G. M., Machalaba, C. C., & Karesh, W. B. (2018). A framework for stimulating economic investments to prevent emerging diseases. Bulletin of the World Health Organization, 96(2), 138–140. https://doi.org/10.2471/blt.17.199547
Schar, Daniel L., Gavin Mark Yamey, Catherine C. Machalaba, and William B. Karesh. “A framework for stimulating economic investments to prevent emerging diseases.” Bulletin of the World Health Organization 96, no. 2 (February 2018): 138–40. https://doi.org/10.2471/blt.17.199547.
Schar DL, Yamey GM, Machalaba CC, Karesh WB. A framework for stimulating economic investments to prevent emerging diseases. Bulletin of the World Health Organization. 2018 Feb;96(2):138–40.
Schar, Daniel L., et al. “A framework for stimulating economic investments to prevent emerging diseases.” Bulletin of the World Health Organization, vol. 96, no. 2, Feb. 2018, pp. 138–40. Epmc, doi:10.2471/blt.17.199547.
Schar DL, Yamey GM, Machalaba CC, Karesh WB. A framework for stimulating economic investments to prevent emerging diseases. Bulletin of the World Health Organization. 2018 Feb;96(2):138–140.
Published In
Bulletin of the World Health Organization
DOI
EISSN
1564-0604
ISSN
0042-9686
Publication Date
February 2018
Volume
96
Issue
2
Start / End Page
138 / 140
Related Subject Headings
- United States
- Tropical Medicine
- Private Sector
- Pandemics
- Investments
- Humans
- Cost of Illness
- Communicable Diseases, Emerging
- 42 Health sciences
- 32 Biomedical and clinical sciences